Macrolide antibiotics in outpatient practice
Journal of Respiratory Medicine · 17.04.2026 · 2 (1) · 49
DOI: 10.17116/respmed2026201149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiratory Medicine, erschienen am 17.04.2026. Verfasst von G.G. Prozorova und 2 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
In outpatient practice, the leading respiratory pathogens are pneumococci and atypical microflora, against which macrolide antibiotics have high microbiological activity. However, the growing resistance of gram-positive pathogens to macrolides due to the uncontrolled use of the latter limits their use. The article discusses the mechanisms of resistance of various types of macrolide antibiotics, the features of their pharmacokinetics and non-antibiotic properties, the advantages of 16-membered macrolides are shown.
Zitieren
APA
Prozorova, G., Budnevsky, A., & Feigelman, S. (2026). Macrolide antibiotics in outpatient practice. Journal of Respiratory Medicine, 2(1), 49. https://doi.org/10.17116/respmed2026201149
Vancouver
Prozorova G, Budnevsky A, Feigelman S. Macrolide antibiotics in outpatient practice. Journal of Respiratory Medicine. 2026;2(1):49. doi:10.17116/respmed2026201149
BibTeX
@article{Prozorova2026,
author = {Prozorova, G.G. and Budnevsky, A.V. and Feigelman, S.N.},
title = {Macrolide antibiotics in outpatient practice},
journal = {Journal of Respiratory Medicine},
year = {2026},
volume = {2},
number = {1},
pages = {49},
doi = {10.17116/respmed2026201149}
}
EUVIMED